Creighton University Cancer Center — Omaha, Nebraska

Creighton University Cancer Center is a clinical research site located in Omaha, Nebraska, United States 68131-2197.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Creighton University Cancer Center has participated in 8 clinical trials.

Therapeutic areas: Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer.

Sponsors: Theradex, NSABP Foundation Inc, Matrix Pharmaceutical.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Creighton University Cancer Center?

Creighton University Cancer Center has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Creighton University Cancer Center conducted?

Creighton University Cancer Center has 8 clinical trials on record. Their work covers Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer.

Is Creighton University Cancer Center accredited by Crixeo Health?

Yes — Creighton University Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Creighton University Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.